PROPOVEN

This brand name is authorized in Estonia, Ireland, Lithuania, UK.

Active ingredients

The drug PROPOVEN contains one active pharmaceutical ingredient (API):

1	Propofol UNII YI7VU623SF - PROPOFOL
	Propofol (2, 6-diisopropylphenol) is a short-acting general anaesthetic agent with a rapid onset of action of approximately 30 seconds.
	Read more about Propofol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PROPOVEN Emulsion for injection/infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01AX10	Propofol	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AX Other general anesthetics
Discover more medicines within N01AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1160851, 1160862, 1160873, 1160884, 1160895, 1160907, 1160918, 1160929, 1160930, 1160941, 1160974, 1160985, 1160996, 1538513, 1538524, 1666223, 1666234, 1666302, 1708387, 1736007, 1830686, 1830697
GB	Medicines & Healthcare Products Regulatory Agency	365334, 365336, 365338, 366128
LT	Valstybinė vaistų kontrolės tarnyba	1017504, 1017505, 1017506, 1017508, 1017509, 1017510, 1017511, 1017512, 1017513, 1017514, 1017515, 1017516, 1017517, 1062020, 1062021, 1071838, 1071839, 1077827, 1079494, 1081699, 1090986, 1090987